Ignite Creation Date:
2025-12-24 @ 9:19 PM
Ignite Modification Date:
2026-01-19 @ 4:05 AM
Study NCT ID:
NCT00845104
Status:
WITHDRAWN
Last Update Posted:
2015-03-06
First Post:
2009-02-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Fludarabine Phosphate, Rituximab, and Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia That Has Relapsed or Not Responded To Treatment
Sponsor:
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Organization: